Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/5097
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | - |
dc.contributor.author | ZANONI, Fernando Luiz | - |
dc.contributor.author | CRUZ, Jose Walber Miranda Costa | - |
dc.contributor.author | MARTINS, Joilson Oliveira | - |
dc.contributor.author | BENABOU, Simon | - |
dc.contributor.author | GRECO, Karin Vicente | - |
dc.contributor.author | MORENO, Ana Carolina Ramos | - |
dc.contributor.author | MARTINEZ, Marina Baquerizo | - |
dc.contributor.author | CALDERARO, Franco Ferraro | - |
dc.contributor.author | SILVA, Mauricio Rocha e | - |
dc.contributor.author | SANNOMIYA, Paulina | - |
dc.date.accessioned | 2014-04-25T21:50:37Z | - |
dc.date.available | 2014-04-25T21:50:37Z | - |
dc.date.issued | 2013 | - |
dc.identifier.citation | SHOCK, v.40, n.1, p.35-44, 2013 | - |
dc.identifier.issn | 1073-2322 | - |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/5097 | - |
dc.description.abstract | We examined the effects of hypertonic saline (HS) on inflammatory, metabolic variables, and bacterial translocation (BT) in rats submitted to intestinal obstruction and ischemia (IO). Male Wistar rats were submitted to IO and treated, 2 h thereafter, with lactated Ringer's (LR) (4 mL/kg per 5 min, i.v.) or HS (7.5% NaCl, 4 mL/kg per 5 min, i.v.). Twenty-four hours after IO, rats were also submitted to enterectomy/enteroanastomosis to resection of necrotized small bowel. Leukocyte-endothelial interactions were investigated by intravital microscopy and the expression of P-selectin and intercellular adhesion molecule 1 by immunohistochemistry. Bacterial cultures of mesenteric lymph nodes, liver, spleen, and blood were used to evaluate BT. Levels of chemokines (cytokine-induced neutrophil chemoattractants 1 and 2), insulin, and corticosterone were determined by enzyme-linked immunosorbent assay. Intestinal histology, serum urea and creatinine levels, and hepatic enzymes activities were performed to evaluate local and remote damage. Relative to IO and LR-treated rats, which exhibited increases in the number of rolling (1.5-fold), adhered (3.5-fold) and migrated (9.0-fold) leukocytes, and increased expression of P-selectin (3-fold) and intercellular adhesion molecule 1 (3-fold) on mesenteric microcirculation, treatment with HS followed by enterectomy reduced leukocyte-endothelial interactions and expression of both adhesion molecules to values attained in sham rats. Serum chemokines were normalized after treatment with both solutions followed by enterectomy. Hypertonic saline-treated rats demonstrated a significant reduction in BT to 50% in liver and spleen samples and bacteremia (14%), compared with 82% of BT in liver and spleen samples of IO and LR-treated rats and bacteremia (57%). Local intestinal damage was attenuated, and renal and hepatic function preserved by treatment with HS followed by enterectomy. Survival rate increased to 86% up to 15 days. Data presented suggest that HS solution followed by enterectomy reduces mesenteric microcirculatory dysfunctions and BT, attenuating local and remote damage in a model of strangulated small bowel obstruction. | - |
dc.description.sponsorship | Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [04/15964-6] | - |
dc.description.sponsorship | Centers of Excellence Program (PRONEX-CNPq/FAPERJ) [66.11251998-2] | - |
dc.language.iso | eng | - |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | - |
dc.relation.ispartof | Shock | - |
dc.rights | restrictedAccess | - |
dc.subject | Gut | - |
dc.subject | sepsis | - |
dc.subject | microcirculation | - |
dc.subject | leukocyte-endothelial interactions | - |
dc.subject | chemokines | - |
dc.subject.other | critically-ill patients | - |
dc.subject.other | ischemia-reperfusion injury | - |
dc.subject.other | hemorrhagic-shock | - |
dc.subject.other | septic shock | - |
dc.subject.other | intestinal microcirculation | - |
dc.subject.other | cecal ligation/puncture | - |
dc.subject.other | leukocyte behavior | - |
dc.subject.other | prostaglandin e(2) | - |
dc.subject.other | organ dysfunction | - |
dc.subject.other | severe sepsis | - |
dc.title | HYPERTONIC SALINE SOLUTION REDUCES MESENTERIC MICROCIRCULATORY DYSFUNCTIONS AND BACTERIAL TRANSLOCATION IN A RAT MODEL OF STRANGULATED SMALL BOWEL OBSTRUCTION | - |
dc.type | article | - |
dc.rights.holder | Copyright LIPPINCOTT WILLIAMS & WILKINS | - |
dc.identifier.doi | 10.1097/SHK.0b013e318299d3fa | - |
dc.identifier.pmid | 23644577 | - |
dc.subject.wos | Critical Care Medicine | - |
dc.subject.wos | Hematology | - |
dc.subject.wos | Surgery | - |
dc.subject.wos | Peripheral Vascular Disease | - |
dc.type.category | original article | - |
dc.type.version | publishedVersion | - |
hcfmusp.author.external | MARTINS, Joilson Oliveira:Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin Anal, Sao Paulo, Brazil | - |
hcfmusp.author.external | GRECO, Karin Vicente:St Bartholomews & Royal London Sch Med, William Harvey Res Inst, London, England | - |
hcfmusp.author.external | MORENO, Ana Carolina Ramos:Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin Anal, Sao Paulo, Brazil | - |
hcfmusp.author.external | MARTINEZ, Marina Baquerizo:Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin Anal, Sao Paulo, Brazil | - |
hcfmusp.author.external | CALDERARO, Franco Ferraro:Univ Guarulhos, Small Anim Vet Hosp, Sao Paulo, Brazil | - |
hcfmusp.description.beginpage | 35 | - |
hcfmusp.description.endpage | 44 | - |
hcfmusp.description.issue | 1 | - |
hcfmusp.description.volume | 40 | - |
hcfmusp.origem | WOS | - |
hcfmusp.origem.id | 2-s2.0-84880078196 | - |
hcfmusp.origem.id | WOS:000330243800007 | - |
hcfmusp.publisher.city | PHILADELPHIA | - |
hcfmusp.publisher.country | USA | - |
hcfmusp.relation.reference | Bagshaw SM, 2009, CRIT CARE MED, V37, P463, DOI 10.1097/CCM.0b013e318194b097 | - |
hcfmusp.relation.reference | Banerjee A, 2013, SHOCK, V39, P366, DOI 10.1097/SHK.0b013e3182894016 | - |
hcfmusp.relation.reference | BOYD AJ, 1994, MICROVASC RES, V47, P355, DOI 10.1006/mvre.1994.1028 | - |
hcfmusp.relation.reference | Chavakis E, 2009, THROMB HAEMOSTASIS, V102, P191, DOI 10.1160/TH08-12-0844 | - |
hcfmusp.relation.reference | Chen LW, 2011, SHOCK, V35, P59, DOI 10.1097/SHK.0b013e3181e86f10 | - |
hcfmusp.relation.reference | COIMBRA R, 1995, SHOCK, V4, P45, DOI 10.1097/00024382-199507000-00007 | - |
hcfmusp.relation.reference | Coimbra R, 2006, J TRAUMA, V60, P41, DOI 10.1097/01.ta.0000197417.03460.0a | - |
hcfmusp.relation.reference | Coimbra R, 1996, J SURG RES, V64, P203, DOI 10.1006/jsre.1996.0329 | - |
hcfmusp.relation.reference | COLLINS T, 1995, FASEB J, V9, P899 | - |
hcfmusp.relation.reference | Deacon CF, 2005, REGUL PEPTIDES, V128, P117, DOI 10.1016/j.regpep.2004.06.007 | - |
hcfmusp.relation.reference | de Groot H, 2007, TRANSPL P, V39, P481, DOI 10.1016/j.transproceed.2006.12.012 | - |
hcfmusp.relation.reference | Farquhar I, 1996, J SURG RES, V61, P190, DOI 10.1006/jsre.1996.0103 | - |
hcfmusp.relation.reference | Khan R, 2011, SHOCK, V36, P440, DOI 10.1097/SHK.0b013e3182336bda | - |
hcfmusp.relation.reference | Lagoa CE, 2004, CRIT CARE, V8, pR221, DOI 10.1186/cc2871 | - |
hcfmusp.relation.reference | Lehmann C, 2006, CLIN HEMORHEOL MICRO, V34, P427 | - |
hcfmusp.relation.reference | Li L, 2009, TRENDS ENDOCRIN MET, V20, P429, DOI 10.1016/j.tem.2009.06.004 | - |
hcfmusp.relation.reference | Lu YQ, 2010, CHINESE MED J-PEKING, V123, P1453, DOI 10.3760/cma.j.issn.0366-6999.2010.11.019 | - |
hcfmusp.relation.reference | Marik PE, 2002, CHEST, V122, P1784, DOI 10.1378/chest.122.5.1784 | - |
hcfmusp.relation.reference | Marik PE, 2004, INTENS CARE MED, V30, P748, DOI 10.1007/s00134-004-2167-y | - |
hcfmusp.relation.reference | Miyoshi T, 2010, IMMUNOLOGY, V131, P331, DOI 10.1111/j.1365-2567.2010.03303.x | - |
hcfmusp.relation.reference | Moore-Olufemi SD, 2005, SHOCK, V23, P258, DOI 10.1097/01.shk.0000155195.17687.00 | - |
hcfmusp.relation.reference | Nakagawa NK, 2006, SHOCK, V26, P180, DOI 10.1097/01.shk.0000223133.10254.82 | - |
hcfmusp.relation.reference | Nakagawa NK, 2007, CLINICS, V62, P321, DOI 10.1590/S1807-59322007000300018 | - |
hcfmusp.relation.reference | Figueiredo Luiz Francisco Poli de, 2002, Acta Cir. Bras., V17, P211, DOI 10.1590/S0102-86502002000400003 | - |
hcfmusp.relation.reference | Poli de Figueiredo LF, 2006, ENDOCRMETAB IMMUNE D, V6, P201 | - |
hcfmusp.relation.reference | Rizoli SB, 1998, J IMMUNOL, V161, P6288 | - |
hcfmusp.relation.reference | Rocca AS, 1999, ENDOCRINOLOGY, V140, P1687, DOI 10.1210/en.140.4.1687 | - |
hcfmusp.relation.reference | Rocha e Silva M, 1986, CIRC SHOCK, V19, P165 | - |
hcfmusp.relation.reference | Shi HP, 2002, SHOCK, V17, P496, DOI 10.1097/00024382-200206000-00010 | - |
hcfmusp.relation.reference | Shih CC, 2008, CRIT CARE MED, V36, P1864, DOI 10.1097/CCM.0b013e318173f982 | - |
hcfmusp.relation.reference | Shukla A, 2004, SHOCK, V21, P391, DOI 10.1097/01.shk.0000125478.37219.48 | - |
hcfmusp.relation.reference | Smalley DM, 2000, INFLAMMATION, V24, P399, DOI 10.1023/A:1007008027483 | - |
hcfmusp.relation.reference | Souza DG, 2004, BRIT J PHARMACOL, V143, P132, DOI 10.1038/sj.bjp.0705862 | - |
hcfmusp.relation.reference | Suliburk J, 2008, EUR SURG RES, V40, P184, DOI 10.1159/000110859 | - |
hcfmusp.relation.reference | Valenza F, 2005, CRIT CARE, V9, P588, DOI 10.1186/cc3818 | - |
hcfmusp.relation.reference | Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300 | - |
hcfmusp.relation.reference | van Haren FMP, 2012, SHOCK, V37, P268, DOI 10.1097/SHK.0b013e31823f152f | - |
hcfmusp.relation.reference | van Minnen LP, 2007, SURGERY, V141, P470, DOI 10.1016/j.surg.2006.10.007 | - |
hcfmusp.relation.reference | Vincent JL, 2005, CRIT CARE, V9, pS9, DOI 10.1186/cc3748 | - |
hcfmusp.relation.reference | WADDELL SC, 1992, J MANIP PHYSIOL THER, V15, P10 | - |
hcfmusp.relation.reference | Yada-Langui MM, 2004, EXP BIOL MED, V229, P684 | - |
hcfmusp.relation.reference | Zanoni FL, 2009, CLINICS, V64, P911, DOI 10.1590/S1807-59322009000900013 | - |
dc.description.index | MEDLINE | - |
dc.identifier.eissn | 1540-0514 | - |
hcfmusp.remissive.sponsorship | CNPq | - |
hcfmusp.remissive.sponsorship | FAPESP | - |
hcfmusp.remissive.sponsorship | CNPq | - |
hcfmusp.remissive.sponsorship | FAPESP | - |
hcfmusp.remissive.sponsorship | FAPERJ | - |
hcfmusp.citation.scopus | 10 | - |
hcfmusp.scopus.lastupdate | 2022-06-24 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - FM/MCP Artigos e Materiais de Revistas Científicas - HC/ICHC Artigos e Materiais de Revistas Científicas - HC/InCor Artigos e Materiais de Revistas Científicas - LIM/08 Artigos e Materiais de Revistas Científicas - LIM/11 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_ZANONI_HYPERTONIC_SALINE_SOLUTION_REDUCES_MESENTERIC_MICROCIRCULATORY_DYSFUNCTIONS_AND_2013.PDF Restricted Access | publishedVersion (English) | 4.87 MB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.